The Claim
Omega-3 fatty acid supplementation increases high-density lipoprotein (HDL) cholesterol by a mean difference of 5.51 mg/dL in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, taking omega-3 fatty acid supplements results in an average increase of 5.51 mg/dL in HDL cholesterol levels.
See the scientific wording
Omega-3 fatty acid supplementation modestly increases high-density lipoprotein (HDL) cholesterol by a mean difference of 5.51 mg/dL in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, suggesting a potential benefit on reverse cholesterol transport.
Omega-3 fatty acids enter the liver and trigger the production of a protein called ApoA-I, which is the main building block of HDL cholesterol. More ApoA-I means more HDL particles form in the liver and enter the bloodstream. These HDL particles pick up excess cholesterol from tissues and carry it back to the liver for disposal, which helps clear fat from the liver and blood.
What the research says
1 studyStudy: Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
This study found that taking omega-3 supplements slightly increases 'good' cholesterol (HDL) in people with fatty liver disease, which may help their bodies remove excess fat from the liver and blood.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.